comparemela.com

Latest Breaking News On - Sanofi us corp - Page 1 : comparemela.com

Dietary Supplement And Personal Care Products Regulatory And Litigation Highlights – May And June 2021 - Media, Telecoms, IT, Entertainment

Dietary Supplement And Personal Care Products Regulatory And Litigation Highlights – May And June 2021 - Media, Telecoms, IT, Entertainment
mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.

Dietary Supplement and Personal Care Products Regulatory and Litigation Highlights – May and June 2021 | Kelley Drye & Warren LLP

Dietary Supplement and Personal Care Products Regulatory and Litigation Highlights – May and June 2021 | Kelley Drye & Warren LLP
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.

Sanofi Misled Buyers About Pain Relief Patches, Suit Says

ADVERTISEMENT Sanofi Misled Buyers About Pain Relief Patches, Suit Says Law360 (May 3, 2021, 7:30 PM EDT) A proposed class of consumers accused Sanofi US Corp. of misrepresenting the strength and longevity of the pain relief provided by its over-the-counter external analgesic patches under the Aspercreme brand in an Illinois federal court suit filed Saturday. Sanofi s Aspercreme patches contain an active ingredient of lidocaine, a topical anesthetic, and purport on their packaging to provide fast acting and max strength pain relief, according to the lawsuit filed by named plaintiff Sherry Cruz. But those claims are misleading, Cruz says, as they imply that the product contains and delivers the maximum amount of lidocaine to the affected area.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.